MICHELLE KUBIK: Open Payments
NPI 1518337393 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 23 payments from 6 companies in 2025. Trend: 2023 $563 · 2024 $518 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $170 |
| Axsome Therapeutics, Inc. | 1 | $90 |
| Tris Pharma Inc | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $19 |
Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, Dyanavel XR, LOREEV XR.
Industry payments across IA — which companies pay providers there.
